Musk Tongxin Dripping Pills for treating Ticagrelor in Patients After Percutaneous Coronary Intervention: Echocardiography Combined with Untargeted Metabolomics

Musk Tongxin Dripping Pills for treating Ticagrelor in Patients After Percutaneous Coronary Intervention: Echocardiography Combined with Untargeted Metabolomics

Objectives: As current clinical practice guidelines, ticagrelor is the suggested therapeutic scheme to prevent adverse cardiovascular events in acute myocardial infarction (AMI) patients undergoing percutaneous coronary intervention (PCI) treatment. However, this therapeutic strategy still fails, an...

Full description

Bibliographic Details
Main Authors: Lyu Nan, Lai Peng, Zhao Jinxia, Guo Mengzhe, Liang Jun, Wang Haibo, Geng Houfa
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Pharmacology
Subjects:
Musk Tongxin Dripping Pill
ticagrelor
echocardiography
untargeted metabolomics
LC-MS
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.731734/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.731734/full

Similar Items